The document is an intimation of scheduled Analyst/Investor Meetings, classified as a regulatory compliance filing under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The event type is a series of in-person meetings with specific institutional investors and analysts. The meetings are scheduled for Wednesday, August 05, 2026, in Hong Kong.
The schedule of meetings is as follows:
1. FMR: 14:00 - 15:00 (HK time), In-person mode
2. Black Rock: 16:00 - 17:00 (HK time), In-person mode
The disclosure and presentation will also be made available on the Company's website at www.starhealth.in.
The document includes a note that the meeting schedule is subject to changes due to exigencies on the part of the analysts or investors.
The signatory and management participant mentioned is Jayashree Sethuraman, who holds the designation of Company Secretary & Compliance Officer.
The document does not contain any financial data, results, guidance, or forward-looking statements. It is purely a scheduling and compliance intimation.
There is no explicit statement regarding the sharing of Unpublished Price Sensitive Information (UPSI) in this announcement.
Additional Notes Section
This is a standalone regulatory filing (Ref: SHAI/B & S/SE/62/2026-27) addressed to BSE Limited and the National Stock Exchange of India Limited.
No financial data, earnings figures, or strategic updates were disclosed in this announcement.
The document was digitally signed by Jayashree Sethuraman, Company Secretary & Compliance Officer, on July 31, 2026, from Chennai.
